219 related articles for article (PubMed ID: 15679349)
1. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice.
Perez XA; Andrews AM
Anal Chem; 2005 Feb; 77(3):818-26. PubMed ID: 15679349
[TBL] [Abstract][Full Text] [Related]
2. Filtration disrupts synaptosomes during radiochemical analysis of serotonin uptake: comparison with chronoamperometry in SERT knockout mice.
Perez XA; Bianco LE; Andrews AM
J Neurosci Methods; 2006 Jun; 154(1-2):245-55. PubMed ID: 16472867
[TBL] [Abstract][Full Text] [Related]
3. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.
Hagan CE; Schenk JO; Neumaier JF
Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992
[TBL] [Abstract][Full Text] [Related]
4. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
5. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
[TBL] [Abstract][Full Text] [Related]
6. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
7. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.
Samuvel DJ; Jayanthi LD; Bhat NR; Ramamoorthy S
J Neurosci; 2005 Jan; 25(1):29-41. PubMed ID: 15634764
[TBL] [Abstract][Full Text] [Related]
8. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
Lu NZ; Eshleman AJ; Janowsky A; Bethea CL
Mol Psychiatry; 2003 Mar; 8(3):353-60. PubMed ID: 12660809
[TBL] [Abstract][Full Text] [Related]
9. Sex and brain region-specific regulation of serotonin transporter activity in synaptosomes in guanine nucleotide-binding protein G(q) alpha knockout mice.
Haase J; Jones AKC; Mc Veigh CJ; Brown E; Clarke G; Ahnert-Hilger G
J Neurochem; 2021 Oct; 159(1):156-171. PubMed ID: 34309872
[TBL] [Abstract][Full Text] [Related]
10. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
11. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).
Ansah TA; Ramamoorthy S; Montañez S; Daws LC; Blakely RD
J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658
[TBL] [Abstract][Full Text] [Related]
12. The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.
Norrholm SD; Horton DB; Dwoskin LP
Neuropharmacology; 2007 Dec; 53(8):982-9. PubMed ID: 18022203
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.
Larsen AK; Brennum LT; Egebjerg J; Sánchez C; Halldin C; Andersen PH
Br J Pharmacol; 2004 Mar; 141(6):1015-23. PubMed ID: 14993096
[TBL] [Abstract][Full Text] [Related]
14. Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.
Hirano K; Seki T; Sakai N; Kato Y; Hashimoto H; Uchida S; Yamada S
Brain Res; 2005 Aug; 1053(1-2):154-61. PubMed ID: 16051196
[TBL] [Abstract][Full Text] [Related]
15. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
[TBL] [Abstract][Full Text] [Related]
16. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.
Thakker DR; Natt F; Hüsken D; van der Putten H; Maier R; Hoyer D; Cryan JF
Mol Psychiatry; 2005 Aug; 10(8):782-9, 714. PubMed ID: 15940298
[TBL] [Abstract][Full Text] [Related]
17. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
[TBL] [Abstract][Full Text] [Related]
18. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
[TBL] [Abstract][Full Text] [Related]
19. Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes.
Hagan CE; Neumaier JF; Schenk JO
J Neurosci Methods; 2010 Oct; 193(1):29-38. PubMed ID: 20713085
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacology of paroxetine.
Nemeroff CB; Owens MJ
Psychopharmacol Bull; 2003; 37 Suppl 1():8-18. PubMed ID: 14566196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
